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ABSTRACT 
 
 
 
 
Cisplatin is an important anti-cancer drug. Structurally, cisplatin is a coordination 
complex, which means that it has a central metallic atom: platinum. Side interactions 
prevent cisplatin from effectively treating cancerous cells by reaction with DNA. 
Cisplatin has a high rate of forming protein adducts, primarily with sulfur containing 
amino acids. To better understand how cisplatin interacts with sulfur containing amino 
acids in the body, a platinum compound with an ethylenediamine ligand attached was 
reacted with N-acetylcysteine and glutathione. The reactions of cysteine with platinum 
were performed at three pH values: 7.0, 8.5, and 10. NMR spectroscopy was used to 
examine these reaction over time. A COSY and HMQC spectrum of glutathione’s 
reaction with platinum were collected to better identify the reaction products. All 
1
H 
NMR spectra were taken on a JOEL Eclipse 500 MHz NMR instrument. The appearance 
of a free ethylenediamine ligand signal, in many cases, suggests that the amino acids 
react to form products in which the ethylenediamine ligand is displaced as the amino 
acids react via both sulfur and nitrogen atoms. 
 
 
 
 
 
Keywords: Cisplatin, ethylenediamine ligand, N-acetylcysteine, glutathione, NMR 
spectroscopy 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
The importance of cisplatin as an anti-cancer drug justifies it as a prime research 
topic. It is particularly effective in treating testicular and ovarian cancers. Although 
cisplatin is effective in treating specific types of cancer, it causes many serious side 
effects. The main side effects cause by cisplatin include nephrotoxicity, neurotoxicity, 
ototoxicity, nausea, and vomiting (O’Dwyer 1999). 
Because cisplatin has a high rate of forming protein adducts, it is not only 
ineffectively absorbed into cells, but it is also less effective at actually targeting 
cancerous DNA. Curtailing protein adduct formation will make cisplatin much more 
effective at targeting cancerous DNA; however, this will require a thorough 
understanding of how cisplatin behaves in the body. Hopefully my research will be a 
small piece to this puzzle, and allow the scientific community to better understand 
cisplatin’s overall behavior. 
Cisplatin is a coordination complex, meaning that it has a central metallic atom. 
The central metallic atom in cisplatin is platinum.  
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Figure 1.1: Cisplatin 
 
Cisplatin works by cross-linking with cancerous DNA. When cisplatin cross-links 
with DNA it prevents the DNA from being replicated and results in cell apoptosis. 
Although cisplatin most commonly forms either intra-strand cross-links or inter-strand 
cross-links DNA adducts, intra-strand cross-links are more effective at damaging 
cancerous cells. This is because the DNA is poorly repaired (Coluccia and Natile 2007). 
Fortunately, the preferred DNA adduct formed by cisplatin is intra-stranded cross-links, 
which occurs about 65% of the time (Eastman 1999). 
Cross-links occur particularly at guanine residues. Because other macromolecules 
in the body, and within individual cells can interact with cisplatin, its effectiveness at 
strictly targeting cancerous DNA is limited. Studies have shown that within 1 day of 
administering cisplatin intravenously, a shocking 65-98% of cisplatin is bound to proteins 
(DeConti et al. 1973).  
Cisplatin is prone to interacting with proteins, particularly sulfur containing 
amino acids. Cisplatin has an especially high affinity towards proteins with cysteine and 
methionine residues because they are the two amino acids that contain sulfur. Cisplatin’s 
interactions with proteins interferes with the drug’s ability to cross-link with DNA, and 
this affects its ability to cause apoptosis in cancerous cells. It has been suggested that the 
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protein adducts are what causes the drug’s harsh side effects and resistance to the drug 
(Kartalou and Essigmann 2001; Reedijk 1999). 
 
Figure 1.2: Cisplatin reacts with N(7) of guanine 
 
Figure 1.3: Cisplatin forms intra-strand cross-links: DNA poorly repaired 
 
Figure 1.4: Trans-platinum forms inter-stand cross-links:  
DNA repaired more efficiently 
Initially, my research looked at how platinum interacted with N-acetylcysteine 
(N-AcCys) over time. Because cisplatin has a central metallic atom of platinum that is 
primarily involved in interactions with other atoms, I specifically studied how platinum 
interacted with N-AcCys. I also looked at how N-AcCys’s interaction with platinum was 
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affected by altering the pH of the environment in which the reaction took place. The pH 
was altered to 7, 8.5, and 10 because the thiol group of N-AcCys has a pKa of ~8.5.  
  
Figure 1.5: N-acetylcysteine 
Next, I transitioned to looking at how platinum interacted with glutathione (GSH). 
GSH is synthesized in most cells within the body, and is a tripeptide, which contains the 
amino acids glutamate, cysteine and glycine. Larger molecules such as GSH have NMR 
spectra with many peaks that are harder to decode. It was necessary to perform 
correlation spectroscopy (COSY) and heteronuclear single quantum coherence 
spectroscopy (HMQC) to help clarify molecular changes in the GSH samples.  
In conclusion, because cisplatin has a central metallic atom of platinum that is 
primarily involved in interactions with other atoms, I specifically studied how platinum 
interacted with cysteine residues, both free cysteine resides and cysteine in GSH. My 
work with platinum interacting with GSH can be compared to my results from cysteine’s 
interaction with platinum. Studying these reactions will further advance the scientific 
communities’ understanding of how cisplatin potentially reacts within the body. 
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Figure 1.6: Reduced Glutathione  
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CHAPTER 2 
 
 
METHODS 
 
 
Synthesis of Platinum Compounds  
Silver oxalate was prepared by mixing equal molar amounts of oxalic acid and 
silver nitrate in water. The reaction was stirred for several hours in an amber vial, and the 
insoluble silver oxalate was collected by vacuum filtration and rinsed with water.  
Dichloro(ethylenediamine)platinum(II) (Pt(en)Cl2) was reacted with an equimolar 
amount of either silver nitrate or silver oxalate and the reaction was stirred in an amber 
vial overnight. The sample was filtered to remove the insoluble silver chloride, and the 
water was removed using a rotary evaporator (rotavap) with heating to leave either 
Pt(en)(NO3)2 or Pt(en)(ox), respectively.  
NMR Spectroscopy  
 
My research project relied on nuclear magnetic resonance (NMR). NMR utilizes a 
powerful magnet to analyze a sample and it produces a spectrum with peaks. All 
1
H 
NMR spectra were taken on a JOEL Eclipse 500 MHz NMR instrument. The chemical 
shift of these peaks was determined in reference to deuterium oxide as a secondary 
reference. These spectrums are also used to identify what interactions are occurring 
within a given sample. 
In general, samples were prepared by weighing out a specific amount of a sample 
in milligrams, and then adding 1 milliliter of deuterium oxide to that sample in a NMR 
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tube. The samples with only N-AcCys were prepared with 1.6 mg of N-AcCys. All three 
samples of N-AcCys and Pt at ~ pH of 7, 8.5, and 10 were made with 1.6 mg of N-
AcCys, 1.7 mg of Pt(en)(ox), and 1 milliliter of deuterium oxide. A vortex was used to 
help dissolve the samples into the solution of deuterium oxide. The desired pH of each 
sample was achieved by adding either sodium deuteroxide to raise the pH, or nitric acid 
in deuterium oxide to lower the pH. These tubes were then labeled, and their contents are 
analyzed by NMR spectroscopy. To follow up, I checked samples again either after 24 
hours and/or after 1 week to track a sample’s reaction progress.  
Both the reduced and oxidized samples of GSH were made with 3.0 mg of GSH 
dissolved in 1 milliliter of deuterium oxide. Another sample of reduced GSH was made 
with 20 mg for COSY and HMQC analysis. To emulate a 1 to 1 molar ratio a sample of 
1.9 mg of Pt(en)(NO3)2 and 3.1 mg of reduced GSH was created. A sample of 6.2 mg of 
reduced GSH and 3.8 mg of Pt(en)(NO3)2 was also created. 
COSY  
COSY is a form of 2-dimensional spectroscopy. Peaks that appear on the diagonal 
are the connected peaks seen in the 1-dimensional NMR. Cross-peaks are the peaks that 
appear to the sides of the diagonal peaks. Cross-peaks represent protons that are 
connected with other protons at least one carbon bond apart. A COSY was taken on the 
sample of 20 mg of reduced GSH and on the sample of 1.9 mg of Pt(en)(NO3)2 and 3.1 
mg of GSH. 
HMQC 
HMQC is also a 2-dimensional spectroscopy that plots molecules against a carbon 
and hydrogen axis. The produced spectrum has a peak for every unique proton that is 
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attached to a molecule’s carbons. Magnetization is transferred from a molecule’s 
hydrogens and carbons in a back-and-forth manner and signals are recorded at 
incremental times. Hydrogen signals are measured and recorded directly, and the 
chemical shift of carbon is measured and recorded secondarily. The series of experiments 
from multiple time increments established the dimensions formed by carbon atoms. A 
HMQC was taken on the sample of 20 mg of reduced GSH and on the sample of 1.9 mg 
of Pt(en)(NO3)2 and 3.1 mg of GSH. 
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CHAPTER 3 
 
 
RESULTS 
 
 
Part 1: N-acetylcysteine and Pt at ~ pH of 7, 8.5, and 10 
 
Figure 3.1 shows the NMR of N-AcCys at pH ~ 7 with no Pt(en)(ox). The peak at 
1.9 ppm represents the methyl H’s of the acetyl group, the peak at 2.75 ppm represents 
the CH2 group, and the peak at 4.2 ppm represents the α-H. After 24 hours the sample 
was analyzed once again by NMR. The two NMR figures show very few differences; 
thus, very little air oxidation of N-AcCys was seen. This suggests that air oxidation of N-
AcCys is a slow process, and should not be a major factor in altering the chemical 
structure of N-AcCys at a pH of 7. The two NMR readings of N-AcCys at pH ~ 7 can be 
used as a baseline to better understand what occurs when N-AcCys reacts with 
Pt(en)(ox). 
Following the same procedures, another sample was made with a pH of 7. 
Pt(en)(ox) was added to this sample of N-AcCys. Figure 3.2 shows N-AcCys and 
Pt(en)(ox) at pH ~ 7. Comparing figure 3.2 to figure 3.1, both at 30 minutes, reveals that 
the only new peak is at 2.35 and that this new peak must be from the ethylenediamine 
(en) ligand attached to platinum. As previously indicated the other peaks at 1.9 ppm, 2.75 
ppm, and 4.2 ppm represents the methyl H’s of the acetyl group, the CH2 group, and the 
α-H respectively.
10 
 
After 24 hours the reaction between N-AcCys and platinum produces a new 
product. After 24 hours the peak at 2.35 ppm, which represented the sample of unreacted 
platinum (ox) has significantly diminished and a new peak at 3.2 ppm has appeared. This 
new peak represents the ethylenediamine (en) ligand when it is not connected to platinum 
(ox).  
The mechanisim for the reaction that results in the en ligand being discociated can 
be explained by previous research. When Pt(en)(ox) is reacted with N-AcCys, the sulfur 
atom of a N-AcCys groups binds to platinum. This process can eventually result in two 
N-AcCys groups being bound to Pt(ox) when enough N-AcCys is available. Next, to gain 
stability, Pt(ox) undergoes chelation, and in this process the en ligand is dissociated 
(Williams et al. 2011). 
 After one week, the peak at 2.35 ppm has completely disappeared, and the peak 
at 3.2 ppm has become even more noticeable. This signals that after one week the 
reaction of N-AcCys and platinum is complete. It appears that all of the en ligand has 
dissociated from platinum (ox). New peaks at 3.1 ppm signal that oxidation has begun to 
occur.  
11 
 
 
Figure 3.1: N-acetylcysteine at pH ~ 7  
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Figure 3.2: N-acetylcysteine and platinum at pH ~ 7 
 
In figure 3.3 a sample of N-AcCys and platinum (ox) at pH ~ 8.5 was used. The 
figures were similar to those of N-AcCys and platinum (ox) at pH ~ 7. The only notable 
difference was that the peaks were smaller and chelation of platinum (ox) by cysteine 
occurred at a slower rate.  
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Figure 3.3: N-acetylcysteine at pH ~ 8.5 
 
The third group of samples involved N-AcCyss and platinum at pH ~ 10. Figure 
3.4 shows N-AcCys without platinum (ox) at pH ~ 10. Comparing figure 3.4 to figure 3.1 
shows that the peak at 4.2 ppm did not materialize.  
This is the peak that represents the α-H of N-AcCys. Like in figure 3.1, the peak 
at 1.9 ppm represents the methyl H’s of the acetyl group, and the peak at 2.75 ppm 
14 
 
represents the CH2 group. After one week significant oxidation was seen in the same 
sample that initially produced figure 3.3.   
Figure 3.5 shows N-AcCys and platinum (ox) at pH ~ 10 at time intervals of 30 
minutes, 24 hours, and 1 week. At pH of ~ 10 the continued trend of smaller, less defined 
peaks is observed. The chelation of platinum is still seen, but it is accompanied by 
significant oxidation of the sample. The graphs prove that the reaction between N-AcCys 
and platinum (ox) is the least efficient at pH ~ 10. 
 
Figure 3.4: N-acetylcysteine at pH ~ 10 
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Figure 3.5: N-acetylcysteine and platinum at pH ~ 10  
 
Part II: Glutathione’s interaction with platinum 
 
Before GSH’s NMRs could be analyzed, a COSY and HMQC was required to 
help assign GSH’s NMR signals. The first COSY and HMQC was run on a sample of 20 
mg of reduced GSH. This was done after an NMR of the sample was recorded. The peak 
on the COSY at 2.0 ppm was assigned to glutamate’s β hydrogens, because it was the 
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only group to be coupled with two cross-peaks at 2.4 and 3.6 ppm. This indicated that 
glutamate’s β hydrogens were in the middle of the two groups it was coupled with: 
glutamte’s α and γ hydrogens.  
The γ hydrogens of glutamate were downfield by cysteine’s thiol group and 
appeared on the COSY at 2.4 ppm. The β hydrogens of cysteine were further downfield 
because of their connection to a thiol group. This peak appeared at 2.75 ppm on the 
COSY. The α hydrogen of glutamate appeared on the COSY at 3.65 ppm. The α 
hydrogens of glycine appeared at 3.8 ppm on the COSY and were the only signals to 
leave no cross-peaks. The α hydrogen of cysteine appeared on the COSY the furthest 
downfield at 4.4 ppm because of its proximity to thiol.  
 
 
Figure 3.6: 20 mg reduced glutathione 
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Figure 3.7: COSY 20 mg reduced glutathione 
 
 
 
 
Figure 3.8: HMQC 20 mg reduced glutathione 
 
After reduced GSH’s peaks had been identified, the NMRs produced for both 
reduced and oxidized GSH could be analyzed. The purpose of these two NMRs was to 
have an idea of what reduced GSH and oxidized GSH looked like before they reacted 
with platinum. In addition, it was important to examine the two samples after two weeks 
to see how air oxidation altered their appearances. Oxidized and reduced GSH’s NMRs 
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are shown in figure 3.9. The results from the COSY and HMQC helped identify the peaks 
seen on reduced and oxidized GSH’s NMRs. 
In oxidized GSH the peak at 4.55 ppm represents glutamate’s β-H, the peak at 4.9 
ppm represents γ-H of glutamate, the peak at 5.3 ppm represents β-H of cysteine, the 
peak at 5.65 ppm represents the α-H of cysteine, the peak at 6.2 ppm represents α-H of 
glutamate, and the peak at 6.35 ppm represents α-H of glycine. 
In reduced GSH the peak at 4.55 ppm represents glutamate’s β-H, the peak at 4.9 
ppm represents the γ-H of glutamate, the peak at 5.3 ppm represents the β-H of cysteine, 
the peak at 6.2 ppm represents the α-H of glutamate, the peak at 6.4 ppm represents the α-
H of glycine, and the peak at 6.95 ppm represents the α-H of cysteine.  
 
Figure 3.9: 3 mg reduced and oxidized glutathione 
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When Pt(en)(NO3)2 was added to reduced GSH, the NMR initially looked 
relatively similar to the NMR with only GSH. After one week the peak at 6.4 ppm, 
signaling α-H of glycine, was reduced and a new peak emerged at 3.2 ppm. The signals at 
4.55 ppm, 4.9 ppm, and 5.3 ppm also diminished in signal strength. This new peak 
represented a slow, but immediate start to the dissociation of the en ligand. 
 
Figure 3.10: 6.2 mg GSH and 3.8 mg Pt 
 
When 1.9 mg of Pt(en)(NO3)2 was added to 3.1 mg of reduced GSH the NMR-
produced, broad-based peaks (figure 3.11). This, combined with the complexity of GSH’s 
structure, required the second COSY and HMQC to clarify the reaction taking place 
between GSH and Pt(en)(NO3)2.   
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Figure 3.11: 1.9 mg Pt(en)(NO3)2 and 3.1mg GSH 
 
 
 
Figure 3.12: COSY 1.9 mg Pt(en)(NO3)2 and 3.1 mg GSH  
 
 
Figure 3.13: HMQC 1.9 mg Pt(en)(NO3)2 and 3.1 mg GSH 
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CHAPTER 4 
 
 
DISCUSSION 
 
 
Cysteine’s thiol group has a typical pKa value of about 8.5. As the pH of cysteine 
approaches 8.5, the thiol group is deprotonated. The pKa of cysteine’s carboxylic acid 
group is around 2 and the pKa of cysteine’s amino group is around 9. At a pH below 2 
both the amino and carboxylic groups are protonated, giving the carboxylic group a 
neutral charge and the amino group a positive charge. At a pH of 9 or above both groups 
are deprotonated and this gives the amino group a neutral charge and the carboxylic 
group a negative charge. 
When the pH is between 2 and 9, cysteine exists in its zwitterionic form. In this 
form, most similar to human physiological pH, the molecule has a neutral charge; the 
amino group’s positive charge balances the carboxylic group’s negative charge. The 
attachment of the acetyl group slightly alters the pKa characteristics of cysteine. Since the 
experiments with N-acetyl cysteine at pH 7 and 8.5 yield virtually the same results, this 
suggests that none of the molecule’s pKa values have been reached. Comparing the 
results from the reaction of N-acetyl cysteine and platinum at a pH of 7 and 8.5 show that 
a slightly higher pH causes platinum to react with N-acetyl cysteine’s thiol group more 
slowly.  
At pH 10 we see changes in the NMR spectrum. The peak at 4.2 ppm is not 
present as in the previous two spectrums. The signal could have either moved under the
22 
 
water signal or else air oxidation could have occurred. The reaction at pH 10 shows that 
the chelation of N-acetyl cysteine occurs at a much slower pace.  
GSH is a molecule abundant in most cells and it contains cysteine. Because of 
GSH’s abundance in cells, it plays a big role in limiting cisplatin’s ability to bind to 
DNA. The results show that the chelation of GSH’s cisplatin group occurs at no 
noticeably slower speed than that of free cisplatin groups. This suggests that GSH’s 
larger structure does not cause steric hindrance in this reaction.  
Figure 4.1 shows the proposed reaction in which glutathione binds to platinum. At 
the conclusion of this reaction the en ligand is displaced so the adduct can form an 
additional chelate ring; having 2 chelate rings makes the adduct more stable. 
In a previous study (Lempers et al. 1987) altering the pH of GSH and a platinum 
complex showed that the 
1
H chemical shifts of cysteine are independent of pH ranging 
from 4 through 10; however all other 
1
H peaks from glutamate and glycine were found to 
be pH dependent. This suggests that the first ethylenediamine complex coordinates with 
GSH’s sulfhydryl group across pH differences. Further experimentation revealed that the 
second ethylenediamine complex also coordinates to the sulfhydryl group.  
The study also found that at a pH below 7, the adduct moves to completion at a 
very fast rate, as the second Pt-binding step occurs much faster than the first Pt-binding 
step. This is perhaps why the GSH sample’s NMR only showed the complete product of 
the reaction and why figures 3.10 and 3.11 show no intermediate products (Lempers et al. 
1987). 
The primary result of a 1:1 ratio of GSH and a platinum complex has previously 
been found to produce 1 new peak within 1 hour. Additionally, this ratio produces a 
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predictable sulfur-bridged product (Oehlsen et al. 2005). In figures 3.10 and 3.11, 1 week 
resulted in 1 new peak, which suggests that only one sulfur-bridged product was 
produced.  
 
 
24 
 
 
 
Figure 4.1: Proposed reaction scheme of Pt(en)(NO3)2 with GSH
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